NASDAQ · Biotechnology

Rocket Pharmaceuticals, Inc. (RCKT) Stock

$2.62 -0.57% NASDAQ: RCKT Healthcare

Valuation

MetricValue
Price$2.62
Market Cap$285.54M
P/E Ratio-16.00
P/B Ratio0.78
P/S Ratio0.00
EPS (TTM)$-2.01
52-Week High$5.45
52-Week Low$2.47
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.76%
ROA-4.08%
ROCE-48.92%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.07
Current Ratio6.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-167.0M$-224.0M$-260.0M$-273.0M$-229.0M
Net Profit$-169.0M$-222.0M$-246.0M$-259.0M$-223.0M
EPS$-2.68$-3.26$-2.92$-2.73$-2.01
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$497.0M$552.0M$566.0M$528.0M$330.0M
Total Liabilities$42.0M$62.0M$74.0M$64.0M$53.0M
Cash$233.0M$141.0M$56.0M$164.0M$78.0M
Borrowings$23.0M$23.0M$25.0M$25.0M$25.0M

Latest News

Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone? Insider Monkey · Jun 25, 2026 Sector Update: Healthcare Stocks Advance Pre-Bell Friday MT Newswires · Jun 12, 2026 Rocket Pharmaceuticals Closes $180 Million Sale of Pediatric Priority Review Voucher MT Newswires · Jun 12, 2026 Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million Business Wire · Jun 12, 2026 Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going? Insider Monkey · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-121.0M$-178.0M$-195.0M$-210.0M$-190.0M
Investing Cash Flow$11.0M$-78.0M$-115.0M$126.0M$103.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-65.0M$-92.0M$-85.0M$108.0M$-86.0M
Free Cash Flow$-129.0M$-187.0M$-211.0M$-216.0M$-190.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.11
EV / EBITDA10.04
FCF Yield-60.96%
Quick Ratio9.24
Interest Coverage-40.53
Return 1Y-2.38%
Return 3Y-81.66%
Return 5Y-91.68%

Ownership

Insiders Held3.10%
Institutions Held89.44%
Institutions Float Held92.30%
Institutional HolderSharesReport Date
RTW Investments LP17,687,7722026-03-31
Blackrock Inc.7,834,7952026-03-31
Citigroup Inc.5,107,7082026-03-31
Vanguard Portfolio Management LLC4,690,2152026-03-31
State Street Corporation4,485,9892026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. is led by CEO Gaurav D. Shah, employs 299 people, headquartered in US, publicly traded since 2015.

Rocket Pharmaceuticals, Inc. (RCKT) stock trades at $2.62 with a market capitalization of $285.54M. The stock is valued at a price-to-earnings (P/E) ratio of -16.00, price-to-book of 0.78, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.47 and $5.45, and currently trades 51.9% below its 52-week high.

On profitability, Rocket Pharmaceuticals, Inc. generates a return on equity (ROE) of -5.76%, return on capital employed of -48.92%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides